Searchable abstracts of presentations at key conferences in endocrinology

ea0059p119 | Neoplasia, cancer & late effects | SFEBES2018

Oncogenic action of pituitary-tumor transforming gene (PBF) in head and neck cancer is associated with poorer overall survival

Read Martin , Modasia Bhavika , Fletcher Alice , Thompson Rebecca , Baker Katie , Nieto Hannah , Campbell Moray , Boelaert Kristien , Turnell Andrew , Smith Vicki , Mehanna Hisham , McCabe Christopher

PBF is a multifunctional proto-oncogene overexpressed in thyroid and other endocrine cancers. Previously we identified a functional interaction between PBF and the tumour suppressor p53 in well-differentiated thyroid cancer (WDTC). Here, we delineate the oncogenic mechanisms of PBF, along with its binding partner PTTG, in head and neck cancer (HNSCC), in which TP53 mutations (mutTP53) are common (>50%). HNSCC tissue revealed significant upregulation of PBF and PTTG mRNA (&...

ea0059p224 | Thyroid | SFEBES2018

Identification of novel sodium iodide symporter (NIS) interactors which modulate radioiodine uptake

Fletcher Alice , Poole Vikki , Thornton Caitlin , Baker Kate , Thompson Rebecca , Nieto Hannah , Alshahrani Mohammed , Read Martin , Turnell Andy , Boelaert Kristien , Smith Vicki , McCabe Chris

Patients termed to have radioiodine-refractory differentiated thyroid cancer (RR-DTC) cannot accumulate sufficient radioiodine for a therapeutic response due to sodium iodide symporter (NIS) dysregulation via diminished expression and/or altered plasma membrane (PM) localisation. Currently, the regulation of NIS localisation remains poorly defined and despite protein-protein interactions being well-described to modulate trafficking events, the NIS interactome is limited. Previ...

ea0037gp.04.02 | Steroids | ECE2015

The modulation of corticosteroid metabolism by hydrocortisone therapy in patients with hypopituitarism increases tissue glucocorticoid exposure

Sherlock Mark , Behan Lucy Ann , Hannon Mark , Alonso Aurora Aragon , Thompson Christopher , Murray Robert , Crabtree Nicola , Hughes Beverly , Arlt Wiebke , Agha Amar , Toogood Andrew , Stewart Paul M

Context: Patients with hypopituitarism have increased morbidity and mortality. There is ongoing debate around the optimum glucocorticoid replacement therapy.Objective: To assess the effect of glucocorticoid replacement in hypopituitarism on corticosteroid metabolism and its impact on body composition.Design and patients: We assessed the urinary corticosteroid metabolite profile (using gas chromatography/mass spectrometry) and body ...

ea0037ep744 | Pituitary: clinical | ECE2015

Symptoms of gonadal dysfunction are more predictive of hypopituitarism than non-specific symptoms in screening for pituitary dysfunction following moderate or severe traumatic brain injury

Hernandez Martin Cuesta , Hannon Mark J , Crowley Rachel K , Behan Lucy Ann , Tormey William , Rawluk Daniel , Delargy Mark , Agha Amar , Thompson Christopher J

Context: The economic and logistic burden of screening for hypopituitarism following moderate/severe traumatic brain injury (TBI) is considerable. Published guidelines suggest prioritisation for screening of patients with symptoms of pituitary dysfunction.Objective: To evaluate the implementation of targeted symptom-based screening for hypopituitarism after moderate/severe TBI, compared with routine consecutive screening.Design: Gr...

ea0070oc4.7 | Pituitary and Neuroendocrinology | ECE2020

Fluid restriction results in a modest rise in plasma sodium concentration in chronic hyponatraemia due to SIAD; results of a prospective randomised controlled trial

Garrahy Aoife , Galloway Iona , Hannon Anne Marie , Dineen Rosemary , O’Kelly Patrick , Tormey William , O’Reilly Michael , Williams David , Sherlock Mark , Thompson Chris

Fluid restriction (FR) is the recommended first-line treatment for chronic hyponatraemia due to syndrome of inappropriate antidiuresis (SIAD) in expert guidelines, despite the lack of prospective data to support its efficacy. We aimed to test the hypothesis that FR was more effective than no treatment. 46 patients with chronic SIAD were randomised to either fluid restriction (1 litre/day, FR) or no specific hyponatraemia treatment (NoTx) for one month. Inclusion criteria were ...

ea0031p364 | Thyroid | SFEBES2013

Clinical performance of fine-needle aspiration biopsy of thyroid nodules in a tertiary referral centre

Glynn Nigel , Hannon Mark , Lewis Sarah , Hillary Patrick , Hill Arnold D K , Keeling Frank , Morrin Martina , McHenry Claire , Smith Diarmuid , Thompson Chris , Leader Mary , Agha Amar

Fine-needle aspiration biopsy (FNAB) is the tool of choice for evaluating thyroid nodules but there is a significant percentage of insufficient or indeterminate aspirates and falsely reassuring results have been reported in up to 6% of cases.We aimed to examine our experience with FNAB among a large cohort of unselected patients with thyroid nodules.239 consecutive patients (211 women) underwent FNA of a thyroid nodule between July...

ea0021p270 | Pituitary | SFEBES2009

Hypothalamic resistance to signals of energy reserve, rather than excess appetite stimulation, may contribute to obesity in CP patients

Crowley Rachel K , Barrett Patricia , Woods Conor , Fleming Michelle , Behan Lucy Ann , O'Sullivan Eoin P , Rogers Bairbre , Agha Amar , Smith Diarmuid , Thompson Christopher J

Obesity is a recognised complication of craniopharyngioma (CP), but its aetiology is not understood. Leptin, which signals energy reserve, and ghrelin, which regulates appetite, are implicated in the development of obesity.Our aim was to assess leptin and ghrelin levels in CP patients and to compare these to normal and BMI-matched controls.CP patients were identified from the local database. All CP patients were on hormone replacem...

ea0019p180 | Endocrine tumours and neoplasia | SFEBES2009

Abiraterone acetate: the novel application of a CYP450c17 inhibitor to the treatment of both prostate and breast cancer

Folkerd E , Attard G , Dearnaley D , Hunt J , Maier G , Molina A , Olmos D , Oomen N , Parker C , Reid A , Thompson E , De Bono J , Dowsett M

Abiraterone acetate is a potent, selective inhibitor of CYP17, a key enzyme that catalyses the conversion of pregnenolone to dehydroepiandrosterone (DHEA) and progesterone to androstenedione. Inhibition of this enzyme causes suppression of the synthesis of both androgens and oestrogens. Hence treatment with abiraterone acetate could impact on the development and progression of hormone-dependent breast and prostate cancers.In a phase I/II1,2 st...

ea0019p300 | Reproduction | SFEBES2009

Plasma kisspeptin levels in hypertensive diseases of pregnancy and the identification of kisspeptin in amniotic fluid

Nijher G , Dhillo W , Chaudhri O , Murphy K , Ramachandran R , Fowler A , Chinthapalli K , Patterson M , Thompson E , Williamson C , Kumar S , Ghatei M , Bloom S

Kisspeptin, encoded by the KiSS-1 gene activates the G protein coupled receptor 54 (GPR54). The kisspeptin/GPR54 system plays an essential role regulating reproductive development. The human placenta has a high expression of both the KiSS-1 and GPR54 genes. Plasma kisspeptin levels increase several thousand fold in pregnancy. The physiological role of kisspeptin in pregnancy is not clear. Kisspeptin causes vasoconstriction during in vitro studies and may play a r...

ea0017p30 | (1) | BSPED2008

Diagnostic accuracy of four modalities: venous thyroid function tests, thyroglobulin, ultrasound and 99mpertechnetate scanning (Quattro mode): in the investigation of newborns referred with TSH elevation

Neumann D , Jones J , Perry R , Kaur H , Maroo S , Attaie M , Thompson E , Butler S , Irwin G , Watt A , Pohlenz J , Donaldson M

Introduction: Thyroid imaging in the newborns referred with TSH elevation is helpful in establishing a lifelong diagnosis of congenital hypothyroidism (CH), in defining the cause and hence assisting with genetic counselling and in gauging thyroxine requirement.Study aims: To compare diagnostic success when using one, two, three or all four (Quattro mode) of the following modalities – pre-treatment venous thyroid function tests (TFTs), quantitative t...